ATE302948T1 - Screeningverfahren für verbindungen welche die melanogenese beeinflussen - Google Patents

Screeningverfahren für verbindungen welche die melanogenese beeinflussen

Info

Publication number
ATE302948T1
ATE302948T1 AT00937135T AT00937135T ATE302948T1 AT E302948 T1 ATE302948 T1 AT E302948T1 AT 00937135 T AT00937135 T AT 00937135T AT 00937135 T AT00937135 T AT 00937135T AT E302948 T1 ATE302948 T1 AT E302948T1
Authority
AT
Austria
Prior art keywords
compounds
screening methods
melanogenesis
influence
influence melanogenesis
Prior art date
Application number
AT00937135T
Other languages
English (en)
Inventor
Seth J Orlow
Prashiela Manga
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22496233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE302948(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ New York filed Critical Univ New York
Application granted granted Critical
Publication of ATE302948T1 publication Critical patent/ATE302948T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/207—Pigmentation disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00937135T 1999-06-29 2000-06-27 Screeningverfahren für verbindungen welche die melanogenese beeinflussen ATE302948T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14156399P 1999-06-29 1999-06-29
PCT/IB2000/000861 WO2001001131A1 (en) 1999-06-29 2000-06-27 Screening methods for compounds that affect melanogenesis

Publications (1)

Publication Number Publication Date
ATE302948T1 true ATE302948T1 (de) 2005-09-15

Family

ID=22496233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00937135T ATE302948T1 (de) 1999-06-29 2000-06-27 Screeningverfahren für verbindungen welche die melanogenese beeinflussen

Country Status (12)

Country Link
EP (1) EP1190248B1 (de)
JP (1) JP2003503705A (de)
KR (1) KR100823383B1 (de)
AT (1) ATE302948T1 (de)
AU (1) AU774007B2 (de)
CA (1) CA2377163A1 (de)
DE (1) DE60022193T2 (de)
HU (1) HUP0201647A3 (de)
IL (2) IL146228A0 (de)
TW (2) TW200718944A (de)
WO (1) WO2001001131A1 (de)
ZA (1) ZA200109205B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) * 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
WO2003095645A1 (en) * 2002-05-09 2003-11-20 New York University Assay for melanogenesis
DE102004007032A1 (de) * 2004-02-12 2005-08-25 Beiersdorf Ag Antisense-Oligonukleotide zur Behandlung von unerwünschter Pigmentierung der Haut und der Haare
JP4819727B2 (ja) * 2007-03-19 2011-11-24 株式会社コーセー 美白成分のスクリーニング方法
WO2009064493A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Tricyclic compounds as melanogenesis modifiers and uses thereof
US8563754B2 (en) 2010-01-28 2013-10-22 New York University Compounds, compositions and methods for preventing skin darkening
US8772252B2 (en) 2011-01-27 2014-07-08 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
JP5563710B2 (ja) * 2013-11-05 2014-07-30 株式会社ファンケル 皮膚色素沈着マーカーとその利用技術
JP7828714B2 (ja) * 2017-11-17 2026-03-12 ロート製薬株式会社 美容組成物、スクリーニング方法及び美容方法
EP3785696A1 (de) 2019-08-28 2021-03-03 B.R.A.I.N. Biotechnology Research And Information Network AG Kosmetische verwendung von aromatische formamidinderivate
CN117677696A (zh) * 2021-05-10 2024-03-08 N·戈尔 用于增加难表达蛋白的产量的工程化细胞

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292291B1 (de) * 1987-05-22 1994-08-10 University Patents, Inc. Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung
CA2054709A1 (en) * 1989-04-26 1990-10-27 Brigitte Bouchard Non-melanocytic, eucaryotic cell constitutively expressing biologically active human tyrosinase and use thereof
US5540914A (en) * 1989-12-15 1996-07-30 The Board Of Regents Of The University Of Oklahoma Pigmentation enhancer and method
JPH0648935A (ja) * 1992-06-02 1994-02-22 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
JP3532945B2 (ja) * 1993-11-16 2004-05-31 ポーラ化成工業株式会社 抗ヒトチロシナーゼモノクローナル抗体
JPH07324095A (ja) * 1994-05-30 1995-12-12 Hideji Itokawa 環状ペプチドシュードステラリン並びにこれを含有するチロシナーゼ活性阻害剤、メラニン生成抑制剤および皮膚化粧料

Also Published As

Publication number Publication date
DE60022193D1 (de) 2005-09-29
TW200718944A (en) 2007-05-16
JP2003503705A (ja) 2003-01-28
EP1190248B1 (de) 2005-08-24
HUP0201647A2 (en) 2002-08-28
TW200716979A (en) 2007-05-01
AU774007B2 (en) 2004-06-10
KR20020042541A (ko) 2002-06-05
AU5241900A (en) 2001-01-31
WO2001001131A1 (en) 2001-01-04
ZA200109205B (en) 2003-04-30
IL146228A (en) 2007-07-24
KR100823383B1 (ko) 2008-04-17
IL146228A0 (en) 2002-07-25
EP1190248A1 (de) 2002-03-27
DE60022193T2 (de) 2006-06-08
CA2377163A1 (en) 2001-01-04
HUP0201647A3 (en) 2011-01-28

Similar Documents

Publication Publication Date Title
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
ES2243801T3 (es) Equivalente de piel/cabello con papilas reconstruidas.
FR2746391B1 (fr) Compositions cosmetiques a base de pyrazolin-4,5-diones, nouvelles pyrazolin-4,5 diones, procedes de preparation et utilisations
DE60110342D1 (de) Alpha-Interferon enthaltende Hautpflegemittel
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
ATE262313T1 (de) Kosmetisches mittel enthaltend maulbeerbaumextrakt und retinoide
ATE302948T1 (de) Screeningverfahren für verbindungen welche die melanogenese beeinflussen
DE69921318D1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
ATE308960T1 (de) Schäumendes haarpflegemittel
MXPA02002118A (es) Composiciones que contienen productos leguminosos.
BR0114059A (pt) Derivados de resorcinol
DE69914752D1 (de) Trichologische lotion für die topische anwendung
WO2002098347A3 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
MXPA02002119A (es) Productos leguminosos.
DE69942505D1 (de) Neuartige retinoide und deren verwendung
MXPA01005586A (es) Composiciones cosmeticas para el cuidado de la piel que contienen 4-cromanona.
ATE224698T1 (de) Oleamid-glycyl-glycine derivate für die kosmetik und/oder dermatologie
DE60044633D1 (de) Nicht therapeutische Verwendung von N-acetylglucosamin zur Hautschälung
IT1302023B1 (it) Composizione cosmetica deodorante e/o idratante.
DE502004002112D1 (de) Kosmetikum zur depigmentierung
DE60235132D1 (de) Sojaprodukte enthaltende Zusammensetzungen
AU5746799A (en) Antiperspirant product and method
ES2127031T3 (es) Utilizacion de octopirox como agente despigmentante.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties